RadNet EBITDA
EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) dari RadNet (RDNT) pada 30 Jul 2026 adalah 90,80 Juta. USD. Tahun sebelumnya, EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) adalah 242,46 Juta. USD — perubahan sebesar -62,55% (lebih rendah).
Get this data via API
Financial Data API
EBITDA
90,80 Juta.USD
YoY
-62,55%
Terakhir Diperbarui:
EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) dari RadNet adalah 2026 90,80 Juta. USD. EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) dari RadNet adalah 2025 242,46 Juta. USD. Menurun -62,55% lebih rendah dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API
RadNet Analisis saham
Apa yang dilakukan RadNet? RadNet Inc is a leading company in the field of diagnostic imaging in the United States. The company was founded in 1985 and has since undergone impressive development. Today, RadNet operates the largest network of diagnostic imaging centers in the United States and offers a comprehensive range of diagnostic and therapeutic procedures.
RadNet's business model is focused on providing high-quality diagnostic imaging services at competitive prices. The company generates most of its revenue by providing imaging services to Medicare patients and private patients funded by insurers and employers. RadNet also offers its services directly to healthcare facilities, including physician practices, hospitals, and clinics.
RadNet offers a wide range of diagnostic imaging services, including X-rays, CT scans, MRI scans, and nuclear medicine procedures. The company also offers specialized imaging services, including mammography, ultrasound, and PET-CT. RadNet, along with its partners, also provides radiation therapy and other cancer treatments.
In recent years, RadNet has also experienced strong development in the field of telemedicine and artificial intelligence (AI). An AI-based image processing platform has been developed to assist in the detection of cancer and other diseases. The platform uses innovative algorithms to read and analyze imaging results faster and more accurately.
The company has also conducted a series of acquisitions in recent years to strengthen its position in the field of diagnostic imaging. In 2017, the company acquired Doshi Diagnostics Imaging Services, which operated in New York City. In 2018, the company entered into a long-term partnership with Florida-based Diagnostic Centers of America (DCA), and in 2020, the company acquired Elite Imaging of South Florida LLC. These acquisitions have helped RadNet strengthen its presence in core markets and expand its reach into new areas.
RadNet has also made a name for itself by developing innovative technology and new models of collaboration. The company has a firm place in the healthcare and research world, working together with respected health systems, academies, and universities to find new ways to diagnose and treat diseases.
In summary, RadNet Inc is a leading company in the field of diagnostic imaging. The company offers high-quality and innovative services tailored to the needs of patients, physicians, and healthcare facilities. RadNet remains committed to achieving the best possible outcomes for its customers and further expanding its position in the market. RadNet adalah salah satu perusahaan paling populer di Eulerpool.
Pertanyaan yang Sering Diajukan tentang saham RadNet
EBITDA (Laba Sebelum Bunga, Pajak, Penyusutan & Amortisasi) RadNet adalah 90,80 Juta. USD pada tahun 2026.
Access this data via the Eulerpool API
Laporan Laba Rugi — RadNet
Semua Metrik Kunci — RadNet
Penilaian
Laporan Laba Rugi
Margin
Neraca
- Total Aset
- Aset Lancar
- Kas & Setara Kas
- Piutang
- Persediaan
- Properti, Pabrik & Peralatan
- Goodwill
- Aset Tidak Berwujud
- Modal sendiri
- Utang
- Utang
- Kewajiban Lancar
- Utang Jangka Panjang
- Utang Jangka Pendek
- Laba Ditahan
- Nilai Buku per Saham
- Nilai Buku Berwujud per Saham
- Modal Kerja
- Investasi
- Hutang Usaha
- Aset Tidak Lancar
- Investasi Jangka Pendek
- Investasi Jangka Panjang
- Utang Bersih
- Saham Treasuri
- Kepentingan Minoritas
- Kewajiban Pajak Tangguhan
- Aset Berwujud Bersih
- Goodwill/Aset
- Aset Tidak Berwujud/Aset
Arus Kas
- Aliran Kas Operasional
- Pengeluaran Modal
- Aliran Kas Bebas
- FCF per Saham
- Dividen yang Dibayarkan
- Pembelian Kembali Saham
- Aliran Kas Investasi
- Aliran Kas Pendanaan
- CapEx / Pendapatan
- Aliran Kas per Saham
- Kompensasi Berbasis Saham
- Perubahan Modal Kerja
- Akuisisi (Bersih)
- Perubahan Kas Bersih
- CapEx/Arus Kas Operasional
- FCF/Laba Bersih
- Konversi FCF
- Konversi Kas
- Total Pembayaran Pemegang Saham
- CapEx/Penyusutan & Amortisasi
Profitabilitas
- ROE
- ROA
- ROCE
- ROIC
- Perputaran Aset
- Perputaran Persediaan
- Perputaran Piutang
- Hari Penjualan Beredar
- Hari Persediaan Beredar
- Hari Hutang Beredar
- Siklus Konversi Kas
- CROIC
- Laba Kotor/Aset
- Perputaran Aset Tetap
- Perputaran Ekuitas
- Perputaran Modal Kerja
- Perputaran Utang Dagang
- Intensitas Modal
- Piutang/Pendapatan
- Persediaan/Pendapatan
- EBIT/Aset
Leverage
Pertumbuhan
- Pertumbuhan Pendapatan
- CAGR Pendapatan 3T
- CAGR Pendapatan 5T
- CAGR Pendapatan 10T
- Pertumbuhan Laba
- Pertumbuhan EPS
- Pertumbuhan EBIT
- EBIT CAGR 3T
- EBIT CAGR 5T
- EBIT CAGR 10T
- Pertumbuhan Dividen
- Pertumbuhan FCF
- Pertumbuhan Nilai Buku
- Earnings CAGR 3T
- Earnings CAGR 5T
- Earnings CAGR 10T
- EPS CAGR 3T
- EPS CAGR 5T
- Pertumbuhan EBITDA YoY
- EBITDA CAGR 3T
- EBITDA CAGR 5T
- Pertumbuhan Laba Kotor
- Pertumbuhan OCF YoY
- Pertumbuhan Karyawan
- Dividend CAGR 3T
- Dividend CAGR 5T
- Dividend CAGR 10T
- Pertumbuhan Aset
- Pertumbuhan Ekuitas
- Pertumbuhan Utang
- Pertumbuhan CapEx
- FCF CAGR 3T
- FCF CAGR 5T
- Pertumbuhan Kapitalisasi Pasar
- Pertumbuhan Jumlah Saham